Page last updated: 2024-12-11

1,3-bis(bis(pyridin-2-ylmethyl)amino)propan-2-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-bis(bis(pyridin-2-ylmethyl)amino)propan-2-ol is a **ligand**, a molecule that binds to a metal ion. It's a complex molecule with a specific structure designed to form stable complexes with certain metal ions, particularly **copper(II)**.

**Here's a breakdown of its structure and significance:**

* **Structure:** The molecule contains two pyridine rings, two methylene groups, and an amino group, all connected to a propan-2-ol backbone.
* **Ligand properties:** The presence of nitrogen atoms in the pyridine rings and the amino group allows it to act as a **chelating ligand**, meaning it can bind to a metal ion through multiple donor atoms. This results in a strong and stable metal-ligand complex.

**Why is it important for research?**

1. **Metal ion coordination:** The ligand's ability to complex with copper(II) makes it a valuable tool in the study of **copper-mediated reactions**. Copper ions are involved in numerous biological processes, and understanding their interactions with ligands like this is crucial for understanding these processes.

2. **Catalyst development:** The ligand can be used to develop **catalysts**, substances that accelerate chemical reactions. Copper complexes with this ligand have shown activity in various catalytic reactions, including oxidation, reduction, and cross-coupling reactions. These catalysts are often highly selective and efficient, making them valuable for various applications, such as the synthesis of pharmaceuticals and other valuable compounds.

3. **Biomedical applications:** Copper complexes of this ligand have also shown promise in **biomedical applications**, including:
* **Antioxidant activity:** The ligand can help to protect cells from damage caused by reactive oxygen species (ROS).
* **Antimicrobial activity:** Copper complexes can exhibit antibacterial and antifungal properties.
* **Drug delivery:** The ligand can be used to design drug delivery systems that target specific cells or tissues.

**Overall, 1,3-bis(bis(pyridin-2-ylmethyl)amino)propan-2-ol is a versatile ligand with significant potential for research in various fields, particularly in catalysis, biomedicine, and materials science.**

1,3-bis(bis(pyridin-2-ylmethyl)amino)propan-2-ol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9875868
SCHEMBL ID3165365
MeSH IDM0502956

Synonyms (9)

Synonym
1,3-bis(bis(pyridin-2-ylmethyl)amino)propan-2-ol
122413-32-5
SCHEMBL3165365
DTXSID90432139
J-004800
n,n,n',n'-tetrakis(2-pyridylmethyl)-2-hydroxy-1,3-diaminopropane
1,3-bis[bis(pyridin-2-ylmethyl)amino]propan-2-ol
2-hydroxy-n,n,n',n'-tetrakis(2-pyridylmethyl)-1,3-propanediamine
1 3-bis[bis(2-pyridylmethyl)amino]-2-pro
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (2.13)29.6817
2010's22 (46.81)24.3611
2020's24 (51.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.49 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index5.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (10.42%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (89.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]